Home » Dynavax Awarded $3 Million Universal Flu Vaccine Grant From NIAID
Dynavax Awarded $3 Million Universal Flu Vaccine Grant From NIAID
Dynavax Technologies Corporation announced that the National Institutes of Allergy and Infectious Disease (NIAID), a division of the National Institutes of Health (NIH), has awarded a two-year $3.25 million grant to continue development of a novel universal influenza vaccine for controlling seasonal and emerging pandemic flu strains.
Dynavax Technologies
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May